|
Match
|
Document |
Document Title |
|
|
7612109 |
Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes
Water soluble iron carbohydrate complex obtainable from an aqueous solution of iron (III) salt and an aqueous solution of the oxidation product of one or more maltrodextrins using an aqueous...
|
|
|
7601705 |
Polymer controlled induced viscosity fiber system and uses thereof
The present invention relates generally to a method of blunting the postprandial glycemic response in a human by feeding an induced viscosity fiber system. The invention also relates to an induced...
|
|
|
7566461 |
Methods for controlling molluscs
Novel materials for controlling molluscs, such as snails and slugs, using carbohydrates including celluloses, hemicellulose complexes, and/or lignin, for inducing death in molluscs. The materials...
|
|
|
7563824 |
Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals
A clathrate formed by: a hyaluronic acid derivative (a), a hyaluronic acid derivative (b 1 ) different from (a), and being able to form a clathrate with (a) and/or a component (b 2 ) not containing...
|
|
|
7452864 |
Use of the cathelicidin LL-37 and derivatives thereof for wound healing
Use of the antimicrobial cathelicidin peptide ll-37, N-terminal fragments of LL-37 or extended sequences of LL-37 having 1-3 amino acids in the C-terminal end, for stimulating proliferation of...
|
|
|
7449444 |
Hydroxyethyl starch-containing polypeptide compositions
The invention provides compositions containing hydroxyethyl starch and polypeptides, including therapeutic polypeptides such as interleukin-11, that provide for enhanced stability of the...
|
|
|
7425542 |
Stabilizing alkylglycoside compositions and methods thereof
The present invention relates to alkylglycoside-containing compositions and methods for increasing the stability, reducing the aggregation and immunogenicity, increasing the biological activity,...
|
|
|
7348360 |
Method and composition for delivering zinc to the nasal membrane
A viscous gel for delivering minor effective amounts of active substances through the nasal membrane into the body.
|
|
|
7338667 |
Pharmaceutical formulation
The present invention concerns an extended release formulation having an accelerating erosion and/or dissolution rate of the surface of the formulation. The formulation comprises a drug having low...
|
|
|
7320962 |
Hemoactive compositions and methods for their manufacture and use
Dried hemoactive materials comprise both a cross-linked biologically compatible polymer and a non-cross-linked biologically compatible polymer. The cross-linked polymer is selected to form a...
|
|
|
7306813 |
Nonwoven webs treated with fixed mobile materials
The present invention describes a means for fixing skin care ingredients on the surface of non-woven webs and cellulosic mats. The active ingredients can be released (deposited) onto the skin by...
|
|
|
7238645 |
Pesticide formulations containing phosphate ester surfactant and alkoxylated lignosulfonate
The present invention relates to a surfactant system for general use in agricultural compositions, including, but not limited to herbicidal, fungicidal and insecticidal formulations comprised of...
|
|
|
RE39713 |
Polymerizable biodegradable polymers including carbonate or dioxanone linkages
Water-soluble macromers including at least one hydrolysable linkage formed from carbonate or dioxanone groups, at least one water-soluble polymeric block, and at least one polymerizable group, and...
|
|
|
7229642 |
Amino acid modulated extended release dosage form
Disclosed herein is a oral extended release dosage form comprising a plurality of granules of an effective amount of a pharmaceutically active compound, at least one amino acid, and an...
|
|
|
7226620 |
Directly compressible tricalcium phosphate
A compressible tricalcium phosphate agglomerate comprises tricalcium phosphate particles, each having an outer surface, and a binder comprising a polyvinylpyrollidone, carrageenan, or a guar gum,...
|
|
|
7183266 |
Dual induced viscosity fiber system and uses thereof
The present invention relates generally to a method of blunting the postprandial glycemic response to a meal by feeding a dual induced viscosity fiber system. The first component of the induced...
|
|
|
7153526 |
Treatment of gastrointestinal infections
A method for combating bacterial infections affecting the gastrointestinal system of humans and animals is provided. The method is achieved by diagnosing a bacterial infection affecting the...
|
|
|
7135197 |
Stable pharmaceutical composition useful for treating gastrointestinal disorders
The present invention provides a pharmaceutical composition comprising at least one pharmaceutically acceptable bismuth-containing compound, at least one pharmaceutically acceptable...
|
|
|
7115586 |
Non-inclusion cyclodextrin complexes
The invention provides a number of methods for enhancing the aqueous solubility of an active ingredient which is insoluble or sparingly soluble in water. In one preferred embodiment, solubilization...
|
|
|
7109255 |
Bioresorbable hydrogel compositions for implantable prostheses
Crosslinked compositions formed from water-insoluble copolymers are disclosed. These compositions are copolymers having a bioresorbable region, a hydrophilic region and at least two cross-linkable...
|
|
|
7084132 |
Artemisinins with improved stability and bioavailability for therapeutic drug development and application
A stable form of artemisinin wherein an artelinic acid or artesunic acid is complexed with cyclodextrin analogs, preferably, β-cyclodextrin. The complexed cyclodextrin artemisinin formulation...
|
|
|
7074824 |
Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
Beta-lapachone, which is poorly soluble in most pharmaceutically acceptable solvents, has demonstrated significant antineoplastic activity against human cancer lines. The present invention...
|
|
|
7067498 |
Polymer controlled induced viscosity fiber system and uses thereof
The present invention relates generally to a method of blunting the postprandial glycemic response in a human by feeding an induced viscosity fiber system. The invention also relates to an induced...
|
|
|
7063837 |
Syrup composition containing phage associated lytic enzymes
The present invention discloses a method and composition for the treatment of bacterial infections by the parenteral introduction of at least one lytic enzyme produced by a bacteria infected with a...
|
|
|
7033578 |
Antimycotic nail varnish composition
The present invention relates to a composition comprising a) at least one antimycotic agent and b) at least one film forming agent wherein component b) is a derivative of chitosan selected from...
|
|
|
RE39079 |
Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
Disclosed herein are compositions comprising a modified starch and a carrageenan, especially iota-carrageenan, where the compositions are suitable for use in manufacturing soft capsules.
|
|
|
7022338 |
Tablets comprising micro-organisms and method for preparation of the tablets
Tablet containing living micro-organisms, produced from a pressed tablet material comprising micro-organisms and oligosaccharides and/or polysaccharides, the tablet material also comprising at...
|
|
|
7019192 |
Composition for filling bone defects
The invention is directed toward a formable bone composition for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing compound of...
|
|
|
7019036 |
Environmentally friendly pesticide compositions
Pesticidal compositions which are environmentally safe, consisting essentially of a minimum risk pesticide in combination with one or more inert ingredients are disclosed.
|
|
|
6992065 |
Sustained release formulations
A composition for sustained release comprises a carrier material containing a non-polymeric, non-water soluble liquid material having a viscosity of at least 5,000 cP at 37° C. that does not...
|
|
|
6974594 |
Method of preparing biological materials and preparations produced using same
Methods for preparing products containing moisture-sensitive materials, including biological materials such as proteins, peptides or live cells, comprising at least the steps: (i) providing a...
|
|
|
6974591 |
Method for producing a controlled-release preparation
The invention concerns a method for producing a controlled-release pharmaceutical preparation with a particle-containing coating, the coating being derived from an aqueous dispersion of a...
|
|
|
6964772 |
Chitosan-xanthan based polyionic hydrogels for stabilization and controlled release of vitamins
A thermo- and photo stable composition comprising a chitosan/xanthan hydrogel including at least one thermo- or photo-sensitive substance chosen among the following: vitamins, amino-acids, nucleic...
|
|
|
6914051 |
Penetrating antibiotic gel for soft tissue diseases
A penetrating antibiotic gel for treating pain, inflammation and other pathological conditions affecting musculoskeletal tissues and other soft tissues of the body. The composition includes an...
|
|
|
6899896 |
Hydrogel-driven layered drug dosage form
A controlled release dosage form for sertraline has a core comprising a sertraline-containing composition and a water-swellable composition wherein the water-swellable composition is in a separate...
|
|
|
6896894 |
Proteins stabilized with polysaccharide gums
Described are heat stable aqueous solutions or gels comprising a biologically effective amount of a protein and an effective stabilizing amount of a polysaccharide gum as well as heat stable...
|
|
|
6894071 |
Medical compositions for intravesical treatment of bladder cancer
Anti-cancer coating compositions comprising 3-hydroxymethyl-5-aziridinyl-1-1-methyl-2-[1H-indole-4,7-dio
ne]propenol (E09) are disclosed. More specifically, the coating compositions comprise EO9...
|
|
|
6893660 |
Stable pharmaceutical compositions without a stabilizer
Stabilized controlled release pharmaceutical preparations are disclosed in which active ingredient degradation is prevented without the use of a stabilizer. The active ingredient is sealed away...
|
|
|
6861075 |
Biocidal compositions comprising an aerated gel containing hydrophobic silica
A storage-stable biocidal aerated gel composition comprises from 30 to 97% by weight of water, from 0.2 to 5% by weight of a gelling agent selected from xanthan gum, sodium alginate and neutralised...
|
|
|
6855727 |
Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
An antifatigue composition for reducing muscular fatigue or the like during or after exercise, which includes an imidazole compound obtained from extracts of fishes, shelifishes, fowl, flesh or the...
|
|
|
6849577 |
Agrochemical formulation
A storage-stable aqueous agrochemical concentrate formulation comprises a) an agrochemical electrolyte such as glyphosate b) a water-insoluble agrochemical system such as diuron c) an...
|
|
|
6844008 |
Tablet composition
A tablet composition containing N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine and a disintegrant, selected from a low substituted hydroxypropylcellulose, sodium carboxymethyl cellulose,...
|
|
|
6841085 |
Hydrogenolysis of 6-carbon sugars and other organic compounds
Methods for hydrogenolysis are described which use a Re-containing multimetallic catalyst for hydrogenolysis of both C—O and C—C bonds. Methods and compositions for reactions of hydrogen over a...
|
|
|
6835718 |
Biocleavable micelle compositions for use as drug carriers
This invention discloses compositions and methods for preparing biocleavable or biodegradable micelle compositions for carrying and releasing drugs and other active agents for therapeutic or other...
|
|
|
6831107 |
Emulsification systems and emulsions
Personal care or cosmetic oil in water emulsions include an oil emulsifier and a combination of a Xanthan polysaccharide and a polyglucomannan polysaccharide to provide enhanced stability even at...
|
|
|
6828334 |
Fenofibrate-cyclodextrin inclusion complexes and their pharmaceutical composition
The present invention relates to pharmaceutical compositions containing fenofibrate in the form of an inclusion complex with cyclodextrin, having high dissolution profile and in vivo enhanced...
|
|
|
6825234 |
Compositions and methods for amelioration of human female sexual dysfunction
The invention provides compositions and methods suitable for ameliorating female sexual dysfunction, and in particular, female sexual arousal disorder. In one embodiment, the invention provides a...
|
|
|
6824792 |
Bioadhesive composition
This invention relates to a method of producing a bioadhesive composition comprising the steps of preparing a solution of a solvent and a polymer mixture wherein the polymer mixture comprises at...
|
|
|
6818624 |
Therapeutic agent for a cancer and method of screening the same, and health-care auxillary food
A therapeutic agent for a cancer comprising a therapeutically effective amount of an active ingredient, wherein the therapeutic agent is used referring to an ability of acting on NK cell antigen...
|
|
|
6790453 |
Encapsulation compositions and process for preparing the same
Encapsulation compositions in which an encapsulate (A) is encapsulated in a matrix (B) may be prepared by: (i) mixing matrix (B) with a liquid plasticizer and encapsulate (A) in an extruder, to...
|